We are live on
!
Find out more
Fidelity International Portfolio holdings
AUM
$129B
1-Year Est. Return
30.83%
This Fund
S&P 500
This Quarter
Est. Return
+6.23%
1 Year Est. Return
+30.83%
3 Year Est. Return
+84.29%
5 Year Est. Return
+110%
10 Year Est. Return
+535.69%
AUM
$29B
AUM Growth
+$2.89B
(+11%)
Cap. Flow
+$1.6B
Cap. Flow
% of AUM
5.52%
Top 10 Holdings %
Top 10 Hldgs %
17.32%
Holding
533
New
67
Increased
191
Reduced
199
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$519M |
| 2 |
Pfizer
PFE
|
+$351M |
| 3 |
Eli Lilly
LLY
|
+$212M |
| 4 |
Devon Energy
DVN
|
+$189M |
| 5 |
Cognizant
CTSH
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$246M |
| 2 |
US Bancorp
USB
|
+$182M |
| 3 |
Comcast
CMCSA
|
+$118M |
| 4 |
AbbVie
ABBV
|
+$115M |
| 5 |
Coca-Cola Europacific Partners
CCEP
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.57% |
| 2 | Technology | 16.55% |
| 3 | Financials | 16.53% |
| 4 | Communication Services | 10.27% |
| 5 | Consumer Staples | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$2.89T
| $742M | 2.56% |
15,965,693
-858,510
| -5% | -$40.3M |
|
2
Citigroup
C
$223B
| $643M | 2.22% |
11,880,674
+826,322
| +7% | +$43.9M |
|
|
3
UBS Group
UBS
$173B
| $521M | 1.8% |
+30,316,557
| New | +$519M |
|
4
Johnson & Johnson
JNJ
$614B
| $484M | 1.67% |
4,625,518
+885,382
| +24% | +$93.3M |
|
|
ESRX
5
DELISTED
Express Scripts Holding Company
ESRX
| $463M | 1.6% |
5,471,745
+57,385
| +1% | +$4.48M |
|
6
Oracle
ORCL
$365B
| $458M | 1.58% |
10,181,525
-265,688
| -3% | -$10.8M |
|
7
JPMorgan Chase
JPM
$925B
| $434M | 1.5% |
6,938,617
+750,908
| +12% | +$45.2M |
|
8
CVS Health
CVS
$139B
| $431M | 1.49% |
4,480,238
-838,170
| -16% | -$73.9M |
|
9
Electronic Arts
EA
$52.4B
| $423M | 1.46% |
8,996,645
-152,399
| -2% | -$6.28M |
|
10
Cisco
CSCO
$445B
| $419M | 1.45% |
15,056,791
-37,411
| -0.2% | -$966K |
|
|
11
Pfizer
PFE
$142B
| $415M | 1.43% |
14,043,778
+12,255,143
| +685% | +$351M |
|
12
Morgan Stanley
MS
$344B
| $387M | 1.34% |
9,974,971
+10,302
| +0.1% | +$366K |
|
13
NetEase
NTES
$77.4B
| $365M | 1.26% |
18,400,585
-1,270,840
| -6% | -$24.3M |
|
|
14
Eli Lilly
LLY
$1.04T
| $363M | 1.25% |
5,263,984
+3,138,241
| +148% | +$212M |
|
15
Verizon
VZ
$186B
| $336M | 1.16% |
7,188,047
+2,515,161
| +54% | +$123M |
|
|
16
Comcast
CMCSA
$85B
| $334M | 1.15% |
11,506,684
-4,310,014
| -27% | -$118M |
|
17
Apple
AAPL
$4.76T
| $329M | 1.14% |
11,939,548
+484,072
| +4% | +$13.2M |
|
|
18
Cognizant
CTSH
$20.4B
| $326M | 1.13% |
6,198,972
+3,421,302
| +123% | +$171M |
|
19
Alphabet (Google) Class C
GOOG
$4.23T
| $307M | 1.06% |
11,602,187
+1,135,951
| +11% | +$30.5M |
|
20
Procter & Gamble
PG
$350B
| $304M | 1.05% |
3,337,712
+1,517,685
| +83% | +$134M |
|
21
Cigna
CI
$76.3B
| $291M | 1% |
2,828,639
-568
| -0% | -$56K |
|
22
New Oriental
EDU
$7.74B
| $274M | 0.94% |
13,412,901
-325,369
| -2% | -$7.06M |
|
23
Gilead Sciences
GILD
$164B
| $271M | 0.93% |
2,870,867
+409,472
| +17% | +$42.3M |
|
24
CME Group
CME
$90.5B
| $266M | 0.92% |
3,004,105
-49,456
| -2% | -$4.19M |
|
25
eBay
EBAY
$49.8B
| $261M | 0.9% |
11,052,287
+5,526,535
| +100% | +$125M |
|
Similar funds
Fidelity International's Q4 2014 Portfolio in Review
As of Q4 2014, Fidelity International held 533 positions worth $29B, up 11% from $26.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Fidelity International deployed $1.6B of net new capital in Q4 2014, opening 67 new positions and adding to 191 existing holdings. Its largest new stake was UBS Group: 30,316,557 shares worth $521M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Amgen, an estimated $246M trimmed.
- Fidelity International's largest Q4 2014 buy was UBS Group: 30,316,557 shares worth $521M.
- Fidelity International added most to Pfizer in Q4 2014, an estimated $351M increase.
- Fidelity International's biggest Q4 2014 reduction was Amgen, cutting an estimated $246M.
- Fidelity International fully exited Coca-Cola Europacific Partners in Q4 2014, selling an estimated $102M.
- Fidelity International's ten largest holdings make up 17% of its $29B portfolio in Q4 2014.
- Fidelity International opened 67 new positions and closed 55 in Q4 2014.
- Fidelity International's portfolio value rose 11% quarter-over-quarter to $29B.
Based on Fidelity International's 13F filing for Q4 2014, filed 17 Feb 2015.